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Abstract 
This paper presents the development of a new technique using the dry-swabbing method for monitoring the 
contamination of pharmaceutical equipment. Black polyester wipes were used to improve the detection limit of the 
visual inspection. A standardized method of producing model impurity was used to produce known contamination of 
the model surface by a variety of compounds ranging from 0 to 500 μg.dm-2. The sample contaminations were dry-
swabbed and evaluated by measuring the intensity of contamination using the computer image analysis. The detected 
intensities of contamination were always proportional to the amount of the impurity applied. The dry-swabbing 
method has been proven to be at least by one order of magnitude more sensitive than mere visual check.  
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(Petr Kluson) 
 
Keywords: Cleaning validation; dry-swabbing; image analysis; decontamination 
1. Introduction 
Cleaning validation is a collection of techniques and processes aimed at maintaining the cleanness 
standards for the pharmaceutical equipment regardless its processing history. The cleaning validation 
procedures are generally aimed at checking and proving, that the residues of the active pharmaceutical 
ingredient, remaining at the surface of the machinery are acceptable after finished cleaning; the 
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acceptance value being related to the toxicity of API in question. In general, the acceptable level of 
residual contamination [1, 2] can vary depending on the compound from several hundreds μg per dm2 of 
the equipment surface to several μg per dm2. Unassisted human eye can only identify contamination 
levels of the several hundred μg per dm2 magnitude [3], thus in most cases some instrumentation is 
required to improve sensitivity. The analysis (usually UV or HPLC) of wet swabs from the equipment 
surface or rinse water represents the industrial standard [4]. Common drawback of both approaches is the 
necessity to take the sample to laboratory and hence the inevitable delay in continued operation of the 
production equipment.  
This study reports the development of a new technique using the dry-swabbing method for monitoring 
the contamination of pharmaceutical equipment that is more readily available for routine monitoring of 
the contamination. The dry-swabbing/image analysis (DSIA) technique employs black polyester wipes 
for dry-swabbing the equipment surface, so as to transfer all, or at least the representative portion of 
contamination to the wipe creating visible stain on its surface. Digital photography and computer image 
analysis can convert the visual information into the numerical intensity, which is proportional to the 
amount of contamination.  
2. Materials and methods 
The study involved a variety of tested compounds, including amlodipin, ibuprofen, paracetamol, 
caffeine, rutin, esculin, losartan etc. and pharmaceutical formulations thereof as a model substances and 
formulations for investigating the test performance. Those substances were provided by courtesy of 
Zentiva company (Czech Republic). 
2.1. Testing equipment and procedure 
The experiments were carried out in laboratory, using plain stainless steel plates, having marked 
square 1 dm2 sample areas. Simulated contamination by any of the model contaminants was created by 
spraying the pre-determined amount of substance solution or suspension over the sample area (fig. 1a). 
The sprayed volume was maintained constant in order to improve reliability and the contamination level 
was changed using different concentration of sprayed solution/suspension. Steel plates were then left to 
dry. This procedure was used to produce a series of stainless steel plates containing known surface 
contamination by selected model contaminant. Contamination levels ranging from 0 to 500 μg.dm-2 were 
generally used. Contaminations over 300 μg.dm-2 were above the visually detectable limit for most 
compounds, on the other hand, the contaminations below 150 μg.dm-2 were not visually detectable. 
Then, each sample area was wiped by folded Black Inspection Wiper Class 10.000 (Vestilab SA, 
Spain) using forceps. The wiping proceeded in a scanning-like manner from left to right edge of the 
sample area and then again in the top-down direction. The contamination was transferred at least partially 
onto the wiper, producing a “dry-swab”, containing visible stain, if there was any contamination to be 
detected. Example of obtained dry-swabs is provided in fig. 2. 
The figure shows, that the size and/or intensity of the stain generally increase with the increasing 
surface contamination. Therefore, it should be possible to use the swabs to quantify the contamination.  
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Fig. 1. (a) spraying the contaminant solution on model surface area; (b) surface contaminated by 500 μg.dm-2 caffeine; (c) surface 
contaminated by 75 μg.dm-2 caffeine 
 
        
Fig. 2. Dry-swabs of stainless-steel sample area contaminated by Ibalgin® suspension (a) 500 μg.dm-2; (b) 300 μg.dm-2; (c) 
75 μg.dm-2 
2.2. Dry-swabs image processing and analysis 
The shape, size and intensity of the stain depend not only on the contamination of tested surface, but 
also on the fine details of the swabbing procedure. Among other effects, the intensity of the stain is 
negatively correlated to its surface area. Hence, it would be difficult to find a reliable relationship 
between any individual parameter of the stain and the contamination level. Therefore, the obtained swabs 
were processed by image analysis. Digital images of the obtained swabs were taken using a digital 
camera. An integral value of luminance was chosen as a representative quantity characterizing the overall 
intensity of the swab. It was obtained from digital images using the following procedure in Adobe 
Photoshop software (Adobe, USA): 
x The effect of varying light conditions during imaging was corrected by calibration using white and 
black standards, 
x The noise and the wiper texture were suppressed by interpolation,  
x The integral value of luminance of the circular area containing the stain I, was determined. The 
background luminance I0 was determined over similar circular area of the same size, but on clean 
unused viper. The difference Inet = I – I0 is taken as the net integral intensity of the swab.  
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The repeatability of the procedure including taking the swab, taking the digital image, and processing 
it by image analysis varied between RSD = 5 – 10 % for all tested compounds and mixtures. 
3. Results and discussion 
The dry-sawabs/image analysis technique was tested on a variety of selected APIs and pharmaceutical 
formulations. Each compound or formulation was tested on five levels of contamination, which were 
supplemented by blank test. The overview of actual contamination levels for all tested species and 
obtained results are provided in the tab. 1. The table shows the blanks normally exhibit very low swab 
intensities. Figures 3 and 4 show the swab intensity being proportional to the contamination level for all 
tested species, but the slope of the proportion varies from one case to another. The relationship is hence 
specific for any particular tested material, but it can be approximated by linear dependence, at least for 
relatively low contamination. Thus, for each material, there can be found a range of contamination, where 
the relationship between that contamination and the swab intensity is linear. Therefore, within such range 
the technique can be used to quickly quantify the amount of contamination on tested surface. 
Table 1. Swab intensities for contamination of model surface by different contaminants 
c, μg.dm-2 500 300 150 75 50 25 5 0 
 I × 10-3 
Amlodipin - 79.2 43.7 24.1 21.1 6.9 - 0.0 
Caffeine 226.6 172.5 109.8 57.0 8.7 0.0 - 0.0 
Ibuprofen - 105.0 47.9 25.0 17.3 12.8 - 0.0 
Losartan - 41.2 44.1 55.8 73.3 40.0 - 2.3 
Nifuroxazide - 446.2 249.1 149.7 121.7 128.5 - 9.9 
Paracetamol - 36.5 36.4 20.6 15.1 1.9 - 0.0 
Rutin - 250.3 208.8 191.9 130.1 53.9 - 0.4 
Valsartan - 320.4 147.1 128.9 87.1 - 56.9 0.0 
Endiex® - 386.1 241.9 175.4 145.3 - 71.8 2.4 
Ibalgin® 207.3 236.7 87.1 42.2 32.0 0.0 - 0.2 
Lozap H® - 216.2 122.2 102.8 92.6 - 40.3 3.9 
Valzap® - 224.1 108.7 71.2 22.9 - 5.9 2.4 
 
The figs. 3 – 4 and data in tab. 1 show certain relationship between active ingredient and respective 
formulation. However the relationship has a long way to go for being universally valid rule, so that 
relevant formulation has to be used for method calibration for each specific compound or mixture, 
whatever is appropriate for the surface being examined. 
The intensity-contamination relationships are linear in wide range for some samples (fig. 3) or they 
may deviate from the linearity at higher concentrations (fig. 4). The deviation can be due to the stain 
oversaturation as it is the case for Ibalgin or due to the unfavorable optical properties of tested material in 
case of losartan. 
The observations above were summarized for all tested compounds in tab. 2, showing the conservative 
estimate of the detection limit (LOD) and the linear range of quantification (ROQ). The LOD estimate is 
expressed as the lowest contamination that was actually tested and produced swab intensity 3 times higher 
than that of blank sample. ROQ reports the range from LOD up to the limit of calibration curve linearity. 
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Fig. 3. Relationship between the swab intensity and contamination of the sample surface by (a) Endiex® formulation and 
nifuroxazide; (b) Valzap® formulation and valsartan 
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Fig. 4. Relationship between the swab intensity and contamination of the sample surface by (a) Ibalgin® formulation and ibuprofen; 
(b) Lozap H® formulation and losartan 
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Table 2. Limits of detection and ranges of quantification of surface contamination by dry-swabbing method for variety of 
pharmaceutical ingredients/formulation 
c, μ.dm-2 LOD ROQ 
Amlodipin < 25 25 - 300 
Caffeine 25 - 50 50 - 300 
Ibuprofen < 25 25 - 300 
Losartan < 25 25 - 75 
Nifuroxazid < 25 25 - 300 
Paracetamol < 25 25 - 150 
Rutin < 25 25 - 100 
Valsartan < 5 5 - 300 
Endiex® < 5 5 - 300 
Ibalgin® 25 - 50 50 - 300 
Lozap H® < 5 5 - 300 
Valzap® 5 - 50 50 - 300 
 
4. Conclusions 
The developed technique of dry-swabs/image analysis was proved useful for quick determination of 
surface contamination by pharmaceutical formulation. All tested substances and formulations exhibited 
statistically significant intensity-contamination relationship. The detected intensities of contamination 
were always proportional to the amount of the impurity applied. Even the smallest test contamination of 
25 μg.dm-2, left apparent contamination stains on the swab, while the zero-level sample showed no visible 
trace of contamination. Most relationships exhibited very god linearity in the contamination ranges of 
interest (25 – 250 μg.dm-2). For higher contamination, the linearity was poor, due to stains over-
saturation, but those contamination levels are so high that they are detectable by unassisted eye. Distinct 
differences among test compounds were observed, thus “per substance” calibration must be performed to 
obtain relevant results. 
It can be concluded that for practical application of this technique, it would be best to prepare a sample 
of swabs in laboratory environment first. These standardized swabs could be afterwards compared 
visually with swabs applied in operating conditions. This would enable the final users to make rapid and 
reliable estimates of the intensity of contamination. The dry-swabbing method has been proven to be at 
least by one order of magnitude more sensitive than simple visual check. 
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